News
MyChesCo on MSN5h
DESTINY-Breast09 Trial Demonstrates Promising Results for ENHERTU in Combination with PertuzumabPositive interim results from the Phase III DESTINY-Breast09 trial revealed that ENHERTU® (fam-trastuzumab deruxtecan-nxki), ...
AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a company (having a market cap of Rs 21,976.25 Crore) operating in Pharmaceuticals sector. AstraZeneca Pharma India Ltd. key ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback